The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible.
Burmans, an independent community pharmacy, was announced as a winner of the Patient Safety Award at the annual Innovation Awards presented by Philadelphia Business Journal and UnitedHealthcare.
In the wake of an Oct. 21 blogpost on Health Affairs, “The $500 Billion Medicare Slowdown: A Story About Part D,” Ralph Neas, president and CEO of the Generic Pharmacuetical Association, issued the following statement.
Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.
The Center for Healthcare Supply Chain Research and the American Association of Colleges of Pharmacy are partnering to provide the nation’s schools of pharmacy a supply chain educational tool surrounding the distribution of specialty pharmaceuticals.
The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.
Boehringer Ingelheim Pharmaceuticals on Monday announced that Ofev (nintedanib) capsules are now available in the United States. Ofev was approved by the Food and Drug Administration on Oct. 15 to treat idiopathic pulmonary fibrosis.
McKesson and Health Mart on Monday featured solutions designed to help community pharmacies deliver better patient care and sustain growth.
Cardinal Health on Monday announced that independent pharmacies can now take advantage of opportunities to co-brand with the Medicine Shoppe and Medicap Pharmacy franchising systems.
A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.